Immunity Inflammation and Disease
免疫炎症和疾病
ISSN: 2050-4527
自引率: 暂无数据
发文量: 72
被引量: 451
影响因子: 2.491
通过率: 暂无数据
出版周期: 未知
审稿周期: 暂无数据
审稿费用: 0
版面费用: 暂无数据
年文章数: 32
国人发稿量: 32

投稿须知/期刊简介:

Immunity, Inflammation and Disease&nbsp;is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology.&nbsp;Immunity, Inflammation and Disease&nbsp;gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including:<br style="box-sizing: border-box;">• cellular and molecular immunology&nbsp;<br style="box-sizing: border-box;">• clinical immunology&nbsp;<br style="box-sizing: border-box;">• allergy&nbsp;<br style="box-sizing: border-box;">• immunochemistry&nbsp;<br style="box-sizing: border-box;">• immunogenetics&nbsp;<br style="box-sizing: border-box;">• immune signalling<br style="box-sizing: border-box;">• immune development&nbsp;<br style="box-sizing: border-box;">• imaging<br style="box-sizing: border-box;">• mathematical modelling&nbsp;<br style="box-sizing: border-box;">• autoimmunity<br style="box-sizing: border-box;">• transplantation immunology<br style="box-sizing: border-box;">• cancer immunologyOriginal research articles, methods papers, editorials and commentaries are published. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.&nbsp;Immunity, Inflammation and Disease&nbsp;considers for publication both papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell.

最新论文
统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读